Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
06/2004
06/16/2004EP1427526A1 Modified alumina catalyst
06/16/2004EP1341763B1 N-alkoxy-4,4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization
06/16/2004EP1282616B1 Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatement of pain
06/16/2004EP1268469B1 N-(heterocyclyl)benzene or pyridine sulphonamides as antithrombotic agents and anticoagulants
06/16/2004EP0979079B1 Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination
06/16/2004EP0977725B1 New fatty acid derivatives
06/16/2004EP0823423B1 1,4-disubstituted piperidine derivatives
06/16/2004EP0815080B1 Di-substituted 1,4-piperidine esters and amides having 5-ht4 antagonistic activity
06/16/2004CN1505614A Process for making amlodipine maleate
06/16/2004CN1505607A Peptide-deformylase inhibitors
06/16/2004CN1504455A Perfluoroalkylanilins
06/16/2004CN1153765C 4-aryl-1-phenylalkyl-1,2,3,6-Tetrahydropyridines having neurotrophic and neuroprotective activity
06/16/2004CN1153764C Substituted benzylaminopiperidine compounds
06/16/2004CN1153763C Remedies/preventives for frequent urination/urinary incontinence and tropone derivatives
06/16/2004CN1153759C Novel delta-amino-gamma-hydroxy-omega-aryl-alkane amide compounds
06/16/2004CN1153568C Compounds active at a novel position on receptor-operated calcium channel useful for treatment of neurological disorders
06/15/2004US6750349 Superior gastrokinetic properties
06/15/2004US6750254 Nitric oxide-releasing amidine—and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same
06/15/2004US6750244 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
06/15/2004US6750238 Aralkyl ester soft drugs
06/15/2004US6750233 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
06/15/2004US6750231 Skin disorders; gastrointestinal disorders
06/15/2004US6750228 Uncontrolled breakdown of connective tissue by metalloproteases is a feature of many pathological conditions
06/15/2004CA2192714C Quasiturbine (qurbine) zero vibration - continuous combustion rotary engine, compressor and pump
06/10/2004WO2004048335A2 Mandelic acid derivatives
06/10/2004WO2004048334A1 Phenyl substituted piperidine compounds for use as ppar activators
06/10/2004WO2004048326A1 Therapeutic agent for respiratory disease containing 4-hydroxypiperidine derivative as active ingredient
06/10/2004WO2004048321A1 Phenylsulfoxide and phenylsulfone derivatives
06/10/2004WO2004048319A1 Novel benzamide compounds for use in mch receptor related disorders
06/10/2004WO2004018424A9 Thin display device
06/10/2004WO2004016589A3 Process for production of highly pure donepezil hydrochloride
06/10/2004WO2003084943A9 Terphenyl derivatives, preparation thereof, compositions containing same
06/10/2004WO2003080631A8 Plasma carboxypeptidase b inhibitors
06/10/2004WO2003059265A3 Compositions and methods for treating heart failure
06/10/2004WO2003033490A9 Synthesis of 4-[(z)-(4-bromophenyl)(ethoxyimino)methyl]-1'-[2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl]-4'methyl-1,4'bipiperidine
06/10/2004US20040110953 Process for the preparation of (S,S)-CIS-2-phenyl-3-aminopiperidine
06/10/2004US20040110952 e.g., N-[1-(3-phenyl-3-[cyclopenytlacetylamino]propyl)-4-piperidinyl]-N-ethyl-4-methanesulfonylphenylacetamide
06/10/2004US20040110947 such as methyl-3-[([2-[(3-chloro-2,2-dimethylpropanoyl)amino]phenyl]thio)methyl]benzoate; lipid/lipoprotein metabolism
06/10/2004US20040110832 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc
06/10/2004US20040110806 Dipeptide derivatives
06/10/2004US20040110805 Sulfur compounds such as 4-[(4-{3-[(2-adamantylamino)sulfonyl]propoxy}phenyl)sulfonyl]- N-hydroxytetrahydro-2H-pyran-4-carboximide, used as antagonists for metalloenzyme and/or aggrecanase activity; tissue repair
06/10/2004US20040110796 preparation of lower alkyl esters of 3-(3,4-dihalophenyl)-2,6-dioxopiperidine-3-propionic acid and the use of the compound in preparing the corresponding acid
06/10/2004US20040110794 Novel piperidine derivatives as modulators of chemokine receptors
06/10/2004US20040110793 Heterocyclo inhibitors of potassium channel function
06/10/2004US20040110767 Acyclic amide and sulfonamide ligands for the estrogen receptor
06/10/2004US20040110753 Tyrosine derivatives
06/10/2004US20040110748 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
06/10/2004US20040110736 Cyclic derivatives as modulators of chemokine receptor activity
06/10/2004US20040110229 for treatment/prevention of chronic obstructive pulmonary disease, chronic bronchitis, irritable bowel syndrome, and urinary incontinence
06/10/2004CA2507509A1 Therapeutic agent for respiratory disease containing 4-hydroxypiperidine derivative as active ingredient
06/10/2004CA2505542A1 Mandelic acid derivatives
06/09/2004EP1426359A1 Process for preparation of piperidin-2-ylacetic acid
06/09/2004EP1202966B1 Piperidine alcohols
06/09/2004EP1043310B1 Biphenylamidine derivatives
06/09/2004EP0927162B1 Process for preparation of 1-alkyl-3-methylpiperidone-2 and 1-alkyl-5-methylpiperidone-2
06/09/2004CN1152859C Novel N-vinyllactam derivatives and polymer thereof
06/09/2004CN1152684C Release-regulating preparations
06/08/2004US6747149 Glucamine salts for treating hepatitis virus infections
06/08/2004US6747044 Neurokinin antagonists
06/08/2004US6747042 N-heterocyclic derivatives useful for treating or preventing neuronal damage associated with neurological disease
06/08/2004US6747037 Treating ocular hypertension or glaucoma; reduced side effects
06/08/2004US6747027 Selectively inhibits in vitro activity of human matrix metalloprotease-13 over in vitro activity of human matrix metalloprotease-1
06/08/2004US6747023 Sulfonyl derivatives
06/08/2004CA2079692C Novel 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
06/03/2004WO2004046132A1 4-tetrazolyl-4phenylpiperidine derivatives for treating pain
06/03/2004WO2004046112A2 3-amino-piperidine derivatives and processes for their preparation
06/03/2004WO2004046111A1 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
06/03/2004WO2004046110A1 Antagonist to melanin-concentrating hormone receptor
06/03/2004WO2004046095A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication
06/03/2004WO2004046091A2 Biaromatic compounds which activate ppar-gama type receptors, and use thereof in cosmetic or pharmaceutical compositions
06/03/2004WO2004045536A2 Method and compositions for temporarily incapaciting subjets
06/03/2004WO2004045533A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
06/03/2004WO2004045518A2 Open chain prolyl urea-related modulators of androgen receptor function
06/03/2004WO2004037248A3 Modulation of peroxisome proliferator activated receptors activity
06/03/2004WO2004009549A3 Piperidines useful for the treatment of central nervous system disorders
06/03/2004WO2003051842A3 Compositions decreasing activity of hormone-sensitive lipase
06/03/2004US20040106792 Biphenyl compound
06/03/2004US20040106788 asymmetric hydrogenation of a lactam-enamide; multi-step synthesis
06/03/2004US20040106652 such as (2S)-3,3-dimethyl-1-[2-(5-phenylpentanoyl) pyrrolidinyl]pentane-1,2-dione which has affinity for immunophilin; for treatment of neurological disorders/neurodegenerative diseases; nerve growth factors; FK binding proteins
06/03/2004US20040106646 Visual function disorder improving agents
06/03/2004US20040106626 amidine containing compounds which inhibit serine proteases
06/03/2004US20040106622 Aryl-substituted alicylic compound and medical composition comprising the same
06/03/2004US20040106599 an aromatic or heteroaromatic amide compound useful as antiproliferative agent
06/03/2004US20040106593 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same
06/03/2004DE10254875A1 Phenylsulfoxid und -sulfon-Derivate Phenylsulfoxide and sulfone derivatives
06/03/2004CA2506415A1 Substituted aryl thioureas and releated compounds; inhibitors of viral replication
06/03/2004CA2503316A1 Method and compositions for temporarily incapacitating subjects
06/03/2004CA2503312A1 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
06/02/2004EP1423381A1 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
06/02/2004EP1423373A2 Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity
06/02/2004EP1423367A1 Solvates of lercanidipine hydrochloride and new crystalline forms of lercanidipine hydrochloride
06/02/2004EP1423356A2 Novel aminobenzoephenones
06/02/2004EP1214589B1 Method and device for detecting and isolating pharmacological compounds being contained in substance mixtures
06/02/2004EP1143971B1 Substituted 1-(piperidin-4-yl)-3-(aryl)-isothioureas, their preparation and therapeutic use
06/02/2004CN1501916A Novel amlodipine camsylate and method for preparing thereof
06/02/2004CN1501915A Bipiperidinyl-derivatives and their use as chemokine receptor inhibitors
06/02/2004CN1501813A Visual function improving agents
06/02/2004CN1152049C Treatment of insulin resistance with growth hormone secretagogues
06/02/2004CN1152030C Novel heterocyclic compounds
06/02/2004CN1152014C N-aryl anthranilic acid derivatives and uses thereof